Trial intelligence / Profile preview

Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia

NCT03061136Phase 4Withdrawn

Sponsor
Palo Alto Veterans Institute for Research
Start
Oct 2016
Primary completion
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of clonazepam in schizophrenia, sponsored by Palo Alto Veterans Institute for Research. Planned start Oct 2016; status: withdrawn.

02

Drugs

clonazepam
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT03061136.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03061136.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call